Sputnik V
ResearchView the employees at
Sputnik V-
Sergey Ivankov Always looking for opportunities, research and business development
-
Tashkent Region, Uzbekistan
-
Rising Star
-
Overview
Sputnik V is the world’s first registered COVID-19 vaccine with proven 91.6% efficacy, based on a human adenoviral vector platform. Registered in over 70 countries.